55 results on '"Reiter, Robert E."'
Search Results
2. PD42-05 CORRELATING PROSTATE-SPECIFIC MEMBRANE ANTIGEN WITH MOLECULAR PATHWAYS IN TREATMENT NAÏVE PROSTATE CANCER
3. Magnetic Resonance Imaging-Guided Biopsy in Active Surveillance of Prostate Cancer
4. Optimizing Spatial Biopsy Sampling for the Detection of Prostate Cancer
5. Predicting Pathological Tumor Size in Prostate Cancer Based on Multiparametric Prostate Magnetic Resonance Imaging and Preoperative Findings
6. The Role of Opioids and Their Receptors in Urological Malignancy: A Review
7. Prostate Cancer Pulmonary Metastasis Presenting as a Ground-Glass Pulmonary Nodule on 68Ga-PSMA-11 PET/CT
8. PD05-03 MOLECULAR HALLMARKS OF MPMRI VISIBILITY IN PROSTATE CANCER
9. MP34-03 AN OPEN-LABEL, NEOADJUVANT PHASE 2 CLINICAL TRIAL COMPARING THE EFFECTS OF AR INHIBITION WITH AND WITHOUT SRC OR MEK INHIBITION ON THE DEVELOPMENT OF EMT IN PROSTATE CANCER: AN OUTCOME REPORT
10. PD40-11 THE ROLE OF 68GA-PSMA PET-CT IN INITIAL STAGING OF TREATMENT-NAïVE HIGH RISK PROSTATE CANCER.
11. A Clinician’s Guide to Next Generation Imaging in Patients With Advanced Prostate Cancer (RADAR III)
12. MP78-20 PREDICTING PATHOLOGIC TUMOR SIZE IN PROSTATE CANCER BASED ON MULTIPARAMETRIC PROSTATE MRI AND PREOPERATIVE FINDINGS
13. Three Tesla Multiparametric Magnetic Resonance Imaging: Comparison of Performance with and without Endorectal Coil for Prostate Cancer Detection, PI-RADS™ version 2 Category and Staging with Whole Mount Histopathology Correlation
14. PI-RADS Version 2 Category on 3 Tesla Multiparametric Prostate Magnetic Resonance Imaging Predicts Oncologic Outcomes in Gleason 3 + 4 Prostate Cancer on Biopsy
15. A 17-Gene Genomic Prostate Score Assay Provides Independent Information on Adverse Pathology in the Setting of Combined Multiparametric Magnetic Resonance Imaging Fusion Targeted and Systematic Prostate Biopsy
16. Pathological and 3 Tesla Volumetric Magnetic Resonance Imaging Predictors of Biochemical Recurrence after Robotic Assisted Radical Prostatectomy: Correlation with Whole Mount Histopathology
17. Focal Therapy Eligibility Determined by Magnetic Resonance Imaging/Ultrasound Fusion Biopsy
18. Wrong to be Right
19. Magnetic Resonance Imaging Underestimation of Prostate Cancer Geometry: Use of Patient Specific Molds to Correlate Images with Whole Mount Pathology
20. Final Results of a Phase I/II Multicenter Trial of WST11 Vascular Targeted Photodynamic Therapy for Hemi-Ablation of the Prostate in Men with Unilateral Low Risk Prostate Cancer Performed in the United States
21. Risk stratification of prostate cancer in the modern era
22. Ultrasensitive Prostate Specific Antigen after Prostatectomy Reliably Identifies Patients Requiring Postoperative Radiotherapy
23. PD44-10 CORRELATION BETWEEN DIAMETER OF PROSTATE CANCER FOCI ON MULTIPARAMETRIC PROSTATE MRI AND WHOLE MOUNT HISTOPATHOLOGY: STRATIFIED BY PI-RADS AND GLEASON SCORE
24. Magnetic Resonance Imaging-Ultrasound Fusion Biopsy for Prediction of Final Prostate Pathology
25. The Influence of Cardiovascular Disease on Health Related Quality of Life in Men With Prostate Cancer: A 4-Year Followup Study
26. QUALITY OF LIFE FOLLOWING TREATMENT FOR LOCALIZED PROSTATE CANCER: 4-YEAR OUTCOMES
27. THE EXPRESSION OF TWIST HAS AN IMPACT ON SURVIVAL IN HUMAN BLADDER CANCER AND IS CORRELATED TO THE SMOKING STATUS
28. Targeting, Imaging, and Therapy Using a Humanized Antiprostate Stem Cell Antigen (PSCA) Antibody
29. An Inverse Relation Between COX-2 and E-cadherin Expression Correlates With Aggressive Histologic Features in Prostate Cancer
30. Prostate Stem Cell Antigen Is a Putative Target for Immunotherapy in Pancreatic Cancer
31. 594: Mouse Models for Induction and Imaging of Bladder Neoplasms
32. 582: P-AKT Pathway Activation and Inhibition Depends on N-Cadherin or P-EGFR Expression in Invasive Human Bladder Cancer Cell Lines
33. 1091: Recombinant Anti-PSCA Antibodies Inhibit Prostate and Bladder Cancer Growthin Xenograft Models and are Superior to Parental Murine Antibody
34. 590: Reg IV. A Promising Marker of Hormone Refractory Metastatic Prostate Cancer
35. 860: Prostate Stem Cell Antigen (PSCA) Expression is Associated with Gleason Score, Seminal Vesicle Invasion, and Capsular Invasion in Prostate Cancer
36. Prostate Stem Cell Antigen Expression is Associated With Gleason Score, Seminal Vesicle Invasion and Capsular Invasion in Prostate Cancer
37. Immunocytochemical Analysis of Prostate Stem Cell Antigen as Adjunct Marker for Detection of Urothelial Transitional Cell Carcinoma in Voided Urine Specimens
38. Preoperative p27 Status is an Independent Predictor of Prostate Specific Antigen Failure Following Radical Prostatectomy
39. Monoclonal Antibody Therapy for Genitourinary Oncology: Promise for the Future
40. Monoclonal Antibody Therapy for Genitourinary Oncology: Promise for the Future
41. Role of prostate stem cell antigen in prostate cancer research
42. COCCIDIOIDOMYCOSIS PRESENTING AS TESTICULAR MASS
43. COCCIDIOIDOMYCOSIS PRESENTING AS TESTICULAR MASS
44. PREOPERATIVE PROSTATE NEEDLE BIOPSY p27 CORRELATES WITH SUBSEQUENT RADICAL PROSTATECTOMY p27, GLEASON GRADE AND PATHOLOGICAL STAGE
45. PREOPERATIVE PROSTATE NEEDLE BIOPSY p27 CORRELATES WITH SUBSEQUENT RADICAL PROSTATECTOMY p27, GLEASON GRADE AND PATHOLOGICAL STAGE
46. QUALITY OF LIFE OUTCOMES AFTER BRACHYTHERAPY FOR EARLY STAGE PROSTATE CANCER
47. QUALITY OF LIFE OUTCOMES AFTER BRACHYTHERAPY FOR EARLY STAGE PROSTATE CANCER
48. EDITORIAL: PROSTATE CANCER DIAGNOSTICS—OBSTACLES AND OPPORTUNITIES
49. MYASTHENIA GRAVIS AS A PARANEOPLASTIC SYNDROME ASSOCIATED WITH RENAL CELL CARCINOMA
50. MONOCLONAL ANTIBODIES AGAINST PROSTATE STEM CELL ANTIGEN (PSCA) DETECT HIGH LEVELS OF PSCA EXPRESSION IN PROSTATE CANCER BONE METASTASES
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.